If we look at the history of automobile production, there's a clear correlation between efficient design (automation), error reduction (reproducible parts), and high product yield (more cars!).
We can apply the same notion of production streamlining and error reduction that made some companies in the automotive industry thrive, to bioengineering. When you treat an experiment as a thing, like a car, you create a supply chain of scientific methods and experimental data (experimental "parts"), and the final product is knowledge of unassailable quality. When you pass around methods and data like that, a whole explosion of computationally-enabled “goodness” will rain down upon science. And the pace of discovery will leap, just like it did for the automotive industry.
Want to see how Riffyn has already been doing this?